Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CXCR4 | FIMM | pan-cancer | AAC | -0.79 | 0.0002 |
mRNA | ARHGAP30 | CCLE | pan-cancer | AAC | -0.45 | 8e-05 |
mRNA | MAP4K1 | CCLE | pan-cancer | AAC | -0.42 | 3e-06 |
mRNA | CYTIP | CCLE | pan-cancer | AAC | -0.41 | 4e-08 |
mRNA | HLA-DPA1 | CCLE | pan-cancer | AAC | -0.38 | 7e-09 |
mRNA | CD74 | CCLE | pan-cancer | AAC | -0.37 | 1e-09 |
mRNA | CD48 | CCLE | pan-cancer | AAC | -0.37 | 2e-06 |
mRNA | MAP4K1 | GDSC1000 | pan-cancer | AAC | -0.36 | 9e-11 |
mRNA | GCSAM | CCLE | pan-cancer | AAC | -0.35 | 2e-08 |
mRNA | ARHGAP30 | GDSC1000 | pan-cancer | AAC | -0.35 | 8e-05 |